EYE AND ORBIT

Clinical trials for EYE AND ORBIT explained in plain language.

Never miss a new study

Get alerted when new EYE AND ORBIT trials appear

Sign up with your email to follow new studies for EYE AND ORBIT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for older brain cancer patients: immunotherapy after chemo shows promise

Disease control Completed

This early-phase study tested whether the immunotherapy drug nivolumab is safe and effective for older adults (65+) with primary CNS lymphoma after they finish high-dose methotrexate chemotherapy. Fourteen participants were enrolled to check for side effects and see if the treatm…

Matched conditions: EYE AND ORBIT

Phase: PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control

Last updated May 12, 2026 13:41 UTC

EYE AND ORBIT

Get alerted when new EYE AND ORBIT trials appear

New hope for older brain cancer patients: immunotherapy after chemo shows promise